This active ingredient, combined with stabilizers and buffers, creates a formulation designed to regulate appetite signaling and improve glucose control
Research suggests this tri-agonist design may help explore mechanisms related to: Body weight regulation through appetite and satiety signaling
In intestinal L-cells - concentrated in the distal ileum and colon - PC1/3 processes proglucagon into GLP-1 , GLP-2, glicentin, and oxyntomodulin
And being at the edge means increased risk of bloating , nausea, and other gastrointestinal side effects that make the experience unpleasant
It is recommended to alternate the injection site each time to ensure proper rotation
However, the agency warns that people should use these weight loss injections only for licensed medical reasons, not for cosmetic weight loss